Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Furosemide and Hydrochlorothiazide Followed by Furosemide for the Treatment of Adults With Nephrotic Edema: A Randomized Trial-Reference-Cited by-同舟云学术

Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Furosemide and Hydrochlorothiazide Followed by Furosemide for the Treatment of Adults With Nephrotic Edema: A Randomized Trial

Published:2017-03 Issue:3 Volume:69 Page:420-427
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Fallahzadeh Mohammad Amin,Dormanesh Banafshe,Fallahzadeh Mohammad Kazem,Roozbeh Jamshid,Fallahzadeh Mohammad Hossein,Sagheb Mohammad Mahdi

Publisher

Elsevier BV

Subject

Nephrology

Reference29 articles.

1. Mechanisms of oedema in nephrotic syndrome: old theories and new ideas;Deschenes;Nephrol Dial Transplant,2003

2. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications;Doucet;Pediatr Nephrol,2007

3. Over- or underfill: not all nephrotic states are created equal;Bockenhauer;Pediatr Nephrol,2013

4. Edema in the nephrotic syndrome: new aspect of an old enigma;Hamm;J Am Soc Nephrol,2003

5. Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies;Duffy;Cells,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amiloride versus furosemide for the treatment of edema in patients with nephrotic syndrome: A pilot study (AMILOR);Acta Physiologica;2024-06

2. The association between polypharmacy and health-related quality of life among older adults with prostate cancer;Journal of Geriatric Oncology;2024-06

3. Amiloride vs. furosemide for the treatment of edema in human nephrotic syndrome: a pilot study (AMILOR);2024-03-29

4. Nephrotic Syndrome: From Pathophysiology to Novel Therapeutic Approaches;Biomedicines;2024-03-03

5. Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome;Journal of Clinical Medicine;2023-11-01